Concourse Financial Group Securities’s Insys Therapeutics, Inc. INSY Stock Holding History

Concourse Financial Group Securities’s Portfolio INSY Stock Details INSY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-18	Closed	–	–	2394
2019 Q4	$0	Hold	18	–	–	﹤0.01%	2186
2019 Q3	$0	Buy	+18	New	–	﹤0.01%	2294

Concourse Financial Group Securities's INSY Position: Q1 2020 in Review

Concourse Financial Group Securities sold out of Insys Therapeutics, Inc. (INSY) in Q1 2020, closing a stake of 18 shares.

Concourse Financial Group Securities first reported a position in INSY in Q3 2019 and held it in 2 quarters. The position peaked at $0 in Q4 2019. 1 fund tracked by Wall St. Rank holds INSY as of Q1 2020.

Concourse Financial Group Securities reported no remaining Insys Therapeutics, Inc. position as of Q1 2020 after selling out during the quarter.
Concourse Financial Group Securities sold 18 Insys Therapeutics, Inc. shares in Q1 2020.
Concourse Financial Group Securities first reported a position in Insys Therapeutics, Inc. in Q3 2019 and held it in 2 quarters.
Concourse Financial Group Securities's Insys Therapeutics, Inc. position peaked at $0 in Q4 2019.
1 fund tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q1 2020.

Based on Concourse Financial Group Securities's 13F filing for Q1 2020, filed 13 May 2020.